The London Stock Exchange
The London Stock Exchange is at the heart of global financial markets and is home to some of the best companies in the world. At the apex of the three great financial centres of London, New York and Tokyo, the London Stock Exchange has built on more than 200 years of integrity, expertise and market knowledge to become the world's most global exchange business.

Equity markets
We enable companies from around the world to raise the capital they need to grow, by listing securities on our highly-efficient, transparent and well-regulated markets. Through our two primary markets the Main Market and AIM we give companies access to one of the worlds deepest and most liquid pools of investment capital. Once companies have been admitted to trading, we use our expertise of the global financial markets to help them maximise the value of their listing in London.

Trading services
We provide the trading platforms used by broking firms around the world to buy and sell securities. Our systems provide fast and efficient access to trading, allowing investors and institutions to tap quickly into equity, bond and derivative markets. Internationally recognised standards of regulation and market practice make our markets some of the most attractive and liquid in the world. More than 300 firms worldwide trade as members of the London Stock Exchange.

Market information
We supply high-quality, real-time prices, news and other information to the global financial community. Strong relationships with data vendors help ensure the markets receive the information they depend upon. We invest heavily in the best technology to create new applications for our data. We work closely with world-class partners to constantly upgrade our products and services.

Derivatives
Our derivatives business is a pioneering diversification beyond our core equity markets. EDX London is our international equity derivatives exchange and our aim is to become the worlds most efficient and liquid market for equity derivatives. The UK covered warrants market is one of the world's fastest growing investment markets. We host five blue-chip issuers offering over 800 warrants and certificates on single stocks and indices in the UK and around the world.

Our strategy is to compete globally in the market for financial transaction services and become the market of choice. We intend to grow our existing business and the reach and scale of our operations, through business development initiatives, acquisitions, joint ventures and alliances where appropriate.

To implement this strategy, we will pursue 3 objectives:

• Reinforcing and extending our position as the premier source of equity market liquidity, benchmark prices and market data in the European time zone


• Operating a diversified business which capitalises on the emergence of an increasingly innovative environment, through leadership in technology and market services


• And thereby delivering superior value to our customers and shareholders

Since its launch in 1999, techMARK - our international market for innovative technology companies - has established itself as a leading global market for shares in businesses at the cutting edge of technological innovation.

We have now launched techMARK mediscience, the world's first international market for healthcare companies. These companies are world leaders in the fields of science and technology and techMARK mediscience recognises the dynamism and huge potential within the healthcare industry. techMARK mediscience is designed to maximise these advantages by catering for the unique requirements of these businesses.

To offer both maximum coverage for companies on these markets and maximum opportunity for interested investors, further information about techMARK and techMARK mediscience is available via:

• the FTSE techMARK All-Share Index that includes all techMARK companies
• the FTSE techMARK 100 Index that excludes the largest companies and focuses on medium and small techMARK companies at the generally faster-growing end of the market
• the FTSE techMARK mediscience Index that is specifically for emerging healthcare companies in the early stages of growth.

FTSE techMARK All-Share index
All companies admitted to techMARK are included in the FTSE techMARK All-Share Index. It is reviewed quarterly and new listings are included within the index straight away.

FTSE techMARK 100 index
The FTSE techMARK 100 index focuses on medium and smaller techMARK companies. It excludes the largest companies and includes the 100 primary listed companies that were below ?4bn market capitalisation at the launch of techMARK. The existing constituents are reviewed quarterly and are subject to minimum liquidity criteria.

FTSE techMARK mediscience index
The FTSE techMARK mediscience index is specifically for emerging healthcare companies in the early stages of growth, so FTSE 100 companies are not included. The existing constituents are reviewed quarterly.

Subscribe to free Financial-Portal.com newsletter